Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mark Merchant

2PUBLICATIONS
24CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 03, 2025
RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy.

Ashley V DiMarco, Mirunalini Ravichandran, Jeff Lau

|Sep 08, 2023
SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment.

Nicole M Sodir, Gaurav Pathria, Joanne I Adamkewicz

Pageof 1

Frequent Collaborators

2 joint publications

Nicole M Sodir

2 joint publications

Danilo Maddalo

1 joint publications

Gaurav Pathria

1 joint publications

Joanne I Adamkewicz

1 joint publications

Elizabeth H Kelley

1 joint publications

Jawahar Sudhamsu

1 joint publications

Roberto Chiarle

1 joint publications

Ashley V DiMarco

1 joint publications

Mirunalini Ravichandran

1 joint publications

Jeff Lau

Frequent Collaborators

2 joint publications

Nicole M Sodir

2 joint publications

Danilo Maddalo

1 joint publications

Gaurav Pathria

1 joint publications

Joanne I Adamkewicz

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

6.3K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

6.3K
See more related videos